Khiron Life Sciences Stock Return On Equity
| KHRWFDelisted Stock | USD 0 0.00 0.00% |
Khiron Life Sciences fundamentals help investors to digest information that contributes to Khiron Life's financial success or failures. It also enables traders to predict the movement of Khiron Pink Sheet. The fundamental analysis module provides a way to measure Khiron Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Khiron Life pink sheet.
Khiron |
Khiron Life Sciences Company Return On Equity Analysis
Khiron Life's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Khiron Life Return On Equity | -0.45 |
Most of Khiron Life's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Khiron Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Khiron Life Sciences has a Return On Equity of -0.4471. This is much lower than that of the sector and significantly lower than that of the Return On Equity industry. The return on equity for all United States stocks is notably higher than that of the company.
Khiron Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Khiron Life's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Khiron Life could also be used in its relative valuation, which is a method of valuing Khiron Life by comparing valuation metrics of similar companies.Khiron Life is currently under evaluation in return on equity category among related companies.
Khiron Fundamentals
| Return On Equity | -0.45 | |||
| Return On Asset | -0.25 | |||
| Revenue | 12.79 M | |||
| EBITDA | (32.03 M) | |||
| Net Income | (33.13 M) | |||
| Total Debt | 705 K | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 3.49 X | |||
| Cash Flow From Operations | (20.4 M) | |||
| Number Of Employees | 10 | |||
| Beta | 1.92 | |||
| Total Asset | 42.27 M | |||
| Net Asset | 42.27 M |
About Khiron Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Khiron Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Khiron Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Khiron Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Khiron Pink Sheet
If you are still planning to invest in Khiron Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Khiron Life's history and understand the potential risks before investing.
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |